Caricamento...
CD28z CARs and Armored CARs
CD19-targeted chimeric antigen receptor (CAR) T cells are currently being tested in the clinic with very promising outcomes. However, limitations to CAR T cell therapy exist. These include lack of efficacy against some tumors, specific targeting of tumor cells without affecting normal tissue and ret...
Salvato in:
| Pubblicato in: | Cancer J |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687893/ https://ncbi.nlm.nih.gov/pubmed/24667958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000034 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|